Category Specific RSS

1AD

AdAlta secures second Japanese patent for its antibody candidate AD-214

The Covid vaccine functioned by introducing the virus into our bodies, thus encouraging them to build antibodies. It was the…

3 years ago

AdAlta approved to commence clinical trials with sniper protein

Innovative biotech company AdAlta (ASX: 1AD) has been approved to commence human clinical trials for its next generation of protein…

5 years ago

AdAlta partners with GE Healthcare to develop i-body diagnostic imaging

Melbourne-based drug development company AdAlta (ASX: 1AD) has been selected by GE Healthcare, one of the world’s largest healthcare companies,…

6 years ago